MyAverix Finance
US · Healthcare
Livewire Ergogenics (LVVV)
Drug Manufacturers - Specialty & Generic
Livewire Ergogenics (LVVV) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LVVV
Livewire Ergogenics (LVVV) — FAQ
What is LVVV's P/E ratio?
The price-to-earnings (P/E) ratio for Livewire Ergogenics (LVVV) is 18.00 (data as of 2026-05-23).
Does Livewire Ergogenics pay a dividend?
Dividend yield is not available in the current snapshot for Livewire Ergogenics (LVVV). Check the MyAverix Finance app for the latest dividend data.
What sector is Livewire Ergogenics in?
Livewire Ergogenics (LVVV) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LVVV listed on?
LVVV is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.